344 related articles for article (PubMed ID: 22926302)
81. Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques?
Veltri A; Garetto I; Pagano E; Tosetti I; Sacchetto P; Fava C
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):76-85. PubMed ID: 18709413
[TBL] [Abstract][Full Text] [Related]
82. Effectiveness and safety of CT-guided percutaneous radiofrequency ablation of adrenal metastases.
Zhou K; Pan J; Yang N; Shi HF; Cao J; Li YM; Zhang HZ; Wang KF; Chen SH
Br J Radiol; 2018 May; 91(1085):20170607. PubMed ID: 29350539
[TBL] [Abstract][Full Text] [Related]
83. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
[TBL] [Abstract][Full Text] [Related]
84. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
85. Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success.
Veltri A; Calvo A; Tosetti I; Pagano E; Genovesio A; Virzì V; Ferrando U; Fontana D; Gandini G
Cardiovasc Intervent Radiol; 2006; 29(5):811-8. PubMed ID: 16832595
[TBL] [Abstract][Full Text] [Related]
86. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
87. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
88. Laparoscopic vs computerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm.
Gao J; Kong J; Ding XM; Ke S; Niu HG; Xin ZH; Ning CM; Guo SG; Li XL; Zhang L; Dong YH; Sun WB
World J Gastroenterol; 2015 May; 21(19):5941-9. PubMed ID: 26019459
[TBL] [Abstract][Full Text] [Related]
89. [Clinical Study of Percutaneous Radiofrequency Ablation for Small Renal Tumor].
Fujiwara R; Yamashita H; Imoto K; Yamazaki M; Kim CJ
Hinyokika Kiyo; 2016 Oct; 62(10):509-514. PubMed ID: 27919123
[TBL] [Abstract][Full Text] [Related]
90. Clinical efficacy of bipolar radiofrequency ablation of small renal masses.
Kroeze SG; Agenant M; Jonges GN; Stein T; Bosch JL
World J Urol; 2015 Oct; 33(10):1535-40. PubMed ID: 25352297
[TBL] [Abstract][Full Text] [Related]
91. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
92. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
93. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
94. [Mid-term follow-up results of laparoscopic radiofrequency ablation for renal cell carcinoma of T1aN0M0 stage].
Song JN; Zhao XZ; Lian HB; Liu GX; Li XG; Zhang GT; Gan WD; Guo HQ
Zhonghua Wai Ke Za Zhi; 2013 Apr; 51(4):320-2. PubMed ID: 23895752
[TBL] [Abstract][Full Text] [Related]
95. Radiofrequency ablation: an alternative treatment method of renal cell carcinoma.
Lui KW; Gervais DA; Mueller PR
Chang Gung Med J; 2004 Aug; 27(8):618-23. PubMed ID: 15553610
[TBL] [Abstract][Full Text] [Related]
96. Renal function outcomes for multifocal renal neoplasms managed by radiofrequency ablation.
Gupta P; Allen BC; Chen MY; Childs DD; Kota G; Zagoria RJ
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1329-35. PubMed ID: 23361116
[TBL] [Abstract][Full Text] [Related]
97. Renal cell carcinoma: radiofrequency ablation with a multiple-electrode switching system--a phase II clinical study.
Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Hasegawa T; Arima K; Sugimura Y; Yamakado K
Radiology; 2013 Apr; 267(1):285-92. PubMed ID: 23315660
[TBL] [Abstract][Full Text] [Related]
98. [CT-guided radiofrequency ablation of renal cell carcinoma in a patient with solitary kidney after contralateral nephrectomy: a case report].
Yasui K; Kanazawa S; Iguchi T; Fujiwara H; Hiraki Y
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jan; 63(1):59-61. PubMed ID: 12645127
[TBL] [Abstract][Full Text] [Related]
99. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
[TBL] [Abstract][Full Text] [Related]
100. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
